Yeleswaram Krishnaswamy — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Yeleswaram Krishnaswamy has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.91M.

Profile

Yeleswaram Krishnaswamy

Krishnaswamy Yeleswaram is an executive at Rapport Therapeutics Inc., serving as Chief Development Officer. In this role, he oversees clinical development strategy and execution for the company’s CNS-focused small-molecule programs. His position places him at the forefront of the company’s efforts to advance transformative therapeutics for central nervous system disorders.

RoleInsider
Notability40/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-04-21RAPPRapport Therapeutics, Inc.S — Open-market sale20.2K$39.99$809K
2026-04-14RAPPRapport Therapeutics, Inc.S — Open-market sale [10b5-1]10.2K$35.08$358K
2026-04-14RAPPRapport Therapeutics, Inc.S — Open-market sale [10b5-1]9.2K$34.97$321K
2026-04-14RAPPRapport Therapeutics, Inc.S — Open-market sale [10b5-1]500$34.98$17K
2026-04-09RAPPRapport Therapeutics, Inc.S — Open-market sale [10b5-1]360$34.90$13K
2026-03-26RAPPRapport Therapeutics, Inc.S — Open-market sale [10b5-1]10.1K$29.99$303K
2026-01-05RAPPRapport Therapeutics, Inc.S — Open-market sale2.8K$30.05$85K
2026-01-05RAPPRapport Therapeutics, Inc.A — Grant or award9.0K—

Companies — Last 90 Days

Frequently Asked Questions

Who is Yeleswaram Krishnaswamy?

Krishnaswamy Yeleswaram is an executive at Rapport Therapeutics Inc., serving as Chief Development Officer. In this role, he oversees clinical development strategy and execution for the company’s CNS-focused small-molecule programs. His position places him at the forefront of the company’s efforts to advance transformative therapeutics for central nervous system disorders.…

How many SEC Form 4 filings has Yeleswaram Krishnaswamy submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Yeleswaram Krishnaswamy been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 7 open-market sales ($1.91M) across all tracked filings.

Where can I see all of Yeleswaram Krishnaswamy's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Yeleswaram Krishnaswamy profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.